NEW YORK, August 11, 2014 /PRNewswire/ --
Today, Analysts Review released its research reports regarding St. Jude Medical, Inc. (NYSE: STJ), Endo International PLC (NASDAQ: ENDP), The Cooper Companies, Inc. (NYSE: COO), Zoetis Inc (NYSE: ZTS) and Illumina, Inc. (NASDAQ: ILMN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5616-100free.
St. Jude Medical, Inc. Research Reports
On July 29, 2014, St. Jude Medical, Inc. (St. Jude Medical) announced that its Board of Directors declared a Q3 2014 cash dividend of $0.27 per common share, equal to the dividend paid during the Q1 2014 and Q2 2014, which brings the total declared dividend for 2014 to $0.81 per share. According to the Company, the Q3 2014 dividend is payable on October 31, 2014, to shareholders of record on September 30, 2014. The full research reports on St. Jude Medical are available to download free of charge at:
http://www.analystsreview.com/Aug-11-2014/STJ/report.pdf
Endo International PLC Research Reports
On July 30, 2014, Endo International PLC (Endo) announced that Shane M. Cooke, President of Alkermes plc, has been appointed to the Company's Board of Directors and to the Company's Audit and Transactions Committee. Roger Kimmel, Chairman of the Board, Endo, said, "I am excited to welcome Shane to our board of directors. He brings exceptional experience in the areas of finance, biotechnology as well as pharmaceutical operations. Our board is looking forward to the perspective Shane will provide related to our strategy and business operations as we continue to focus on delivering value for our customers and shareholders." The full research reports on Endo are available to download free of charge at:
http://www.analystsreview.com/Aug-11-2014/ENDP/report.pdf
The Cooper Companies, Inc. Research Reports
On August 4, 2014, The Cooper Companies, Inc. (Cooper) scheduled the release of its Q3 2014 financial results on Thursday, September 4, 2014, at 4:00 p.m. ET, followed by a conference call at 5:00 p.m. ET to discuss the results and the Company's current corporate developments. According to Cooper, a live webcast of the call will be available on its website, where a replay will be available until Thursday, September 11, 2014. The full research reports on Cooper are available to download free of charge at:
http://www.analystsreview.com/Aug-11-2014/COO/report.pdf
Zoetis Inc Research Reports
On July 31, 2014, Zoetis Inc (Zoetis) reported that its Board of Directors has declared a Q3 2014 dividend of $0.072 per share of the Company's common stock, payable on Tuesday, September 2, 2014, to holders of record on Wednesday, August 20, 2014. The full research reports on Zoetis are available to download free of charge at:
http://www.analystsreview.com/Aug-11-2014/ZTS/report.pdf
Illumina, Inc. Research Reports
On July 31, 2014, Illumina, Inc. (Illumina) announced that Jeff Huber, Senior Vice President at Google Inc., has been appointed to the Company's Board of Directors. Jay Flatley, CEO, Illumina, said, "We are pleased to welcome Jeff to the Illumina Board and to leverage his expertise as we work to make genomic data accessible to the widest possible community of researchers and clinicians. As a pioneer in big data analytics and highly scalable informatics, Jeff's perspective will greatly benefit our efforts to harness massive amounts of genomic data to accelerate the discovery of new associations between the human genome and disease." The full research reports on Illumina are available to download free of charge at:
http://www.analystsreview.com/Aug-11-2014/ILMN/report.pdf
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review
